AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9695894
Drug: Inspiratory muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspiratory muscle therapy (inspiratory muscle training, inspiratory muscle rest)
Trial: 7888387
Drug: Craniospinal irradiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Craniospinal irradiation and chemotherapy
Trial: 2171446
Drug: Aluminum plus
RxNorm normalized name: aluminum hydroxide / magnesium hydroxide / simethicone Chewable Tablet [Mintox Plus]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aluminum plus citrate (as Shohl's solution)
Trial: 21278617
Drug: ACWY‐TT (tetravalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACWY‐TT (tetravalent meningococcal conjugate vaccine)
Trial: 21278617
Drug: Men‐PS (licensed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Men‐PS (licensed tetravalent meningococcal polysaccharide vaccine)
Trial: 19032560
Drug: Lidocaine 10
RxNorm normalized name: lidocaine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 10 mg/ml
Trial: 17156291
Drug: Placebo (rabies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (rabies vaccine)
Trial: 17156291
Drug: HIV vaccine
RxNorm normalized name: AAV-2 HIV Vaccine
DrugBank: TGAAC09 (DB06363)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIV vaccine (administered to placebo patients at trial closeout)
Trial: 15494897
Drug: Valacyclovir at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir at 1000 mg twice daily for 5 days
Trial: 18008230
Drug: Valacyclovir at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir at 500 mg twice daily
Trial: 11226098
Drug: FBM: fentanyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FBM: fentanyl (25 microg) and bupivacaine (2.5 mg) plus morphine (150 microg)
Trial: 11226098
Drug: FB: fentanyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FB: fentanyl (25 microg) and bupivacaine (2.5 mg)
Trial: 11154952
Drug: CHO solution
RxNorm normalized name: G-CSF (CHO cell derived)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO solution containing 1.7 g CHO/kg(body weight)
Trial: 11154952
Drug: Isocaloric solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isocaloric solution containing 1.2 g CHO/kg(body weight) plus 0.5 g protein/kg(body weight) (including 5 g arginine)
Trial: 8989740
Drug: Usual-protein diet
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual-protein diet (1.3 g/kg per day)
Trial: 31685813
Drug: Topiramate (50-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (50-200 mg/day)
Trial: 20456211
Drug: Glipizide 5
RxNorm normalized name: glipizide 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glipizide 5 mg/day (up-titrated to 20 mg/day)
Trial: 17429836
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy with imatinib (Ind(IM))
Trial: 17429836
Drug: Induction therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction therapy with multiagent, age-adapted chemotherapy (Ind(chemo))
Trial: 17429836
Drug: Combined imatinib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined imatinib and chemotherapy consolidation
Trial: 16338283
Drug: Sitagliptin (1.5-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin (1.5-600 mg)
Trial: 27811278
Drug: Testosterone/Oestradiol combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone/Oestradiol combination
Trial: 25361769
Drug: γ-Tocopherol (γ-T)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: γ-Tocopherol (γ-T) rich mixture of tocopherols (γ-TmT), 500 mg
Trial: 25361769
Drug: Nicotine replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine replacement therapy (NRT) with γ-TmT
Trial: 25361769
Drug: Nicotine replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine replacement therapy (NRT) alone (placebo)
Trial: 16413892
Drug: Midazolam 0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.03 mg/kg, remifentanil: propofol (1:500) at 40 microg/kg/min
Trial: 16413892
Drug: Midazolam 0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.03 mg/kg, fentanyl 1 microg/kg, propofol at 140 microg/kg/min
Trial: 12380231
Drug: Fermi-type rabies
RxNorm normalized name: rabies virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fermi-type rabies vaccine (0.25 ml) administered to groups 2-5 of mice for 14 consecutive days.
Trial: 12380231
Drug: Fermi-type rabies
RxNorm normalized name: rabies virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fermi-type rabies vaccine for human PEP (prescribed dosage).
Trial: 12380231
Drug: Phenolized saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenolized saline (0.25 ml) administered to group 1 of mice for 14 consecutive days.
Trial: 9251974
Drug: 0.25% quinine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% quinine hydrochloride solution
Trial: 8119426
Drug: Topical amethocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical amethocaine
Trial: 3670697
Drug: Motor Activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Motor Activation Therapy (MAT)
Trial: 3670697
Drug: Buflomedil +
RxNorm normalized name: buflomedil
DrugBank: Buflomedil (DB13510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buflomedil + Motor Activation Therapy (MAT)
Trial: 29338476
Drug: Carboxytherapy (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboxytherapy (subcutaneous infusion)
Trial: 28449368
Drug: omarigliptin 25
RxNorm normalized name: Omarigliptin
DrugBank: Omarigliptin (DB11992)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: omarigliptin 25 mg once weekly
Trial: 28449368
Drug: sitagliptin 50
RxNorm normalized name: SITagliptin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sitagliptin 50 mg once daily
Trial: 26612980
Drug: SHRED (multi-ingredient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SHRED (multi-ingredient supplement)
Trial: 23612106
Drug: 27.6 mg
RxNorm normalized name: alanine 27.6 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 27.6 mg of iron (ferrous fumarate enriched with 13% haem iron) daily for 12 weeks
Trial: 23612106
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg ferrosulphate daily for 12 weeks
Trial: 21225090
Drug: NOMAC/E2 (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NOMAC/E2 (2.5 mg/1.5 mg)
Trial: 21225090
Drug: LNG/EE (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LNG/EE (100 μg/20 μg)
Trial: 18394916
Drug: Postoperative concomitant
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative concomitant chemo-radiation consisting of 60Gy external-beam radiotherapy and temozolomide (TMZ) administered concomitantly (75mg/m² daily) and after radiotherapy (150-200mg/m², for 5 days every 4 weeks)
Trial: 18394916
Drug: Nitrosourea-based chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrosourea-based chemotherapy or temozolomide re-challenge at time of recurrence/progression
Trial: 16460667
Drug: Treatment expectancy
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment expectancy
Trial: 8844442
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg daily for 15 days (morning administration)
Trial: 8844442
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg daily for 15 days (evening administration)
Trial: 6588486
Drug: Metronidazole (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (1500 mg infused during 50 minutes)
Trial: 6588486
Drug: Tinidazole (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinidazole (1500 mg infused during 50 minutes)
Trial: 29533000
Drug: Ibrutinib (420
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibrutinib (420 mg until disease progression or unacceptable toxicity)
Trial: 24423369
Drug: Bone marrow
RxNorm normalized name: bone marrow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone marrow cell (BMC) therapy in non-smokers
Trial: 24423369
Drug: Bone marrow
RxNorm normalized name: bone marrow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone marrow cell (BMC) therapy in smokers
Trial: 16796710
Drug: Nadroparin 2850
RxNorm normalized name: Nadroparine
DrugBank: Nadroparin (DB08813)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadroparin 2850 IU (0.3 mL)
Trial: 16796710
Drug: Enoxaparin 4000
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 4000 IU (40 mg)
Trial: 12752349
Drug: PCM (pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCM (pantoprazole 40 mg, clarithromycin 500 mg, metronidazole 500 mg)
Trial: 14632678
Drug: PCA (pantoprazole,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCA (pantoprazole, clarithromycin, amoxicillin 1000 mg)
Trial: 3815457
Drug: Pinaverium bromide
RxNorm normalized name: pinaverium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pinaverium bromide (15 mg)
Trial: 21414133
Drug: Flapless implants
RxNorm normalized name: tolnaftate
DrugBank: Tolnaftate (DB00525)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flapless implants
Trial: 21414133
Drug: Conventional implants
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional implants (flap-group)
Trial: 17697901
Drug: Ebastine fast-dissolving
RxNorm normalized name: melatonin
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ebastine fast-dissolving tablet 20 mg
Trial: 17697901
Drug: Desloratadine capsule
RxNorm normalized name: Desloratadine
DrugBank: Desloratadine (DB00967)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desloratadine capsule 5 mg
Trial: 3578948
Drug: Fresh gas
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh gas flow of 482.5 +/- 186.6 ml X min‐1 (Group A)
Trial: 3578948
Drug: Fresh gas
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh gas flow of 2000 ml X min‐1 (Group B)
Trial: 3578948
Drug: Fresh gas
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh gas flow adjusted to 7145 +/- 986 ml X min‐1 (Group C)
Trial: 26824527
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg tamsulosin alone
Trial: 26824527
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg tamsulosin with 0.5 mg dutasteride daily for 12 months
Trial: 23275019
Drug: Intravenously administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenously administered golimumab
Trial: 21641522
Drug: Light therapy
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light therapy at 10,000 lux
Trial: 21641522
Drug: Usual standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual standard of care and light therapy at 50 lux
Trial: 18047629
Drug: 2.5% CP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% CP 1.0 mL (Group A)
Trial: 18047629
Drug: 2.5% CP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% CP 1.2 mL (Group B)
Trial: 18047629
Drug: 2.5% CP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% CP 1.4 mL (Group C)
Trial: 18047629
Drug: 2.5% CP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% CP 1.6 mL (Group D)
Trial: 17195601
Drug: Neuroscience strategies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroscience strategies applied in psychological treatment research
Trial: 11938860
Drug: Yinchen Dandao
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yinchen Dandao decoction (YCDDD) administered orally for 1 week starting 3 days after operation
Trial: 9080642
Drug: Deslorelin (2.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deslorelin (2.2 mg, subcutaneously as a short-term implant)
Trial: 8401637
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy following radical cystectomy
Trial: 8401637
Drug: Adjuvant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant therapy following cystectomy or aggressive TUR
Trial: 25346595
Drug: Color-coded BP
RxNorm normalized name: SALON CODE Glam Hair Color Glam Brown KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Color-coded BP booklet for daily home BP measurement
Trial: 23744819
Drug: Ketamine 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.3 mg kg(‐1) i.v.
Trial: 20593151
Drug: 200 IU
RxNorm normalized name: Vitamin E 200 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 IU daily vitamin D
Trial: 20593151
Drug: 400 IU
RxNorm normalized name: Vitamin D 400 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 IU daily vitamin D
Trial: 11964551
Drug: Indinavir (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indinavir (1200 mg orally)
Trial: 9485556
Drug: Phenytoin (third
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenytoin (third dose)
Trial: 7803948
Drug: Vinorelbine as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinorelbine as second-line chemotherapy
Trial: 7803948
Drug: Vinorelbine (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vinorelbine (oral dosage form)
Trial: 31990424
Drug: Vonoprazan 20
RxNorm normalized name: vonoprazan 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vonoprazan 20 mg once daily (V20)
Trial: 31990424
Drug: Rabeprazole 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 40 mg twice daily (R40)
Trial: 20401354
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) alone or in conjunction with conservative treatment
Trial: 20401354
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) prior to conservative treatment
Trial: 20401354
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) combined with biofeedback, conservative treatment, and/or self-care
Trial: 16293806
Drug: Volumen (0.1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Volumen (0.1% barium suspension), 1200 mL over 30 minutes
Trial: 16293806
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (water and methylcellulose solution), 1200 mL over 30 minutes
Trial: 1676779
Drug: TPGS (d‐alpha‐tocopheryl‐polyethylene‐glycol‐1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPGS (d‐alpha‐tocopheryl‐polyethylene‐glycol‐1000 succinate) 25 mg/kg daily
Trial: 29320594
Drug: Oxymetazoline hydrochloride
RxNorm normalized name: Oxymetazoline Hydrochloride
DrugBank: Oxymetazoline (DB00935)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxymetazoline hydrochloride cream 1.0% applied once daily for 29 days
Trial: 29320594
Drug: Vehicle applied
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vehicle applied once daily for 29 days
Trial: 29320594
Drug: Oxymetazoline hydrochloride
RxNorm normalized name: Oxymetazoline Hydrochloride
DrugBank: Oxymetazoline (DB00935)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxymetazoline hydrochloride cream 1.0%
Trial: 22034656
Drug: Clonidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (150 μg p.o.)
Trial: 18221408
Drug: G12 (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G12 (12 weeks therapy)
Trial: 18221408
Drug: G24 (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G24 (24 weeks therapy)
Trial: 18221408
Drug: G36 (36
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G36 (36 weeks therapy)
Trial: 18221408
Drug: G48 (48
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G48 (48 weeks therapy)
Trial: 15739210
Drug: CHO (carbohydrate-rich
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO (carbohydrate-rich drink) 50 kcal/100 ml, 290 mOsm/kg; 800 ml evening before surgery and 400 ml 2 hours before anaesthesia
Trial: 15739210
Drug: Placebo; 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo; 800 ml evening before surgery and 400 ml 2 hours before anaesthesia
Trial: 15087294
Drug: Prednisolone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (30 mg/day for 7 days)
Trial: 9309457
Drug: NSAID (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAID (600 mg of Sulindac for one day)
Trial: 9309457
Drug: Estrogen replacement
RxNorm normalized name: Norethindrone Acetate 1mg, Ethinyl Estradiol 5mcg Oral tablet [Estrogen Replacement/Osteoporosis]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen replacement therapy (transdermal system 50 micrograms/d, twice a week, Systen) for 3 months
Trial: 2943820
Drug: Indomethacin 50
RxNorm normalized name: indomethacin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 50 mg i.v. pretreatment
Trial: 24573971
Drug: Cisatracurium (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisatracurium (0.03 mg/kg)
Trial: 22945403
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (280 mg docosahexaenoic acid and 110 mg eicosapentaenoic acid)
Trial: 18682511
Drug: Teriparatide after
RxNorm normalized name: Teriparatide
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Teriparatide after prior treatment with risedronate
Trial: 18682511
Drug: Teriparatide after
RxNorm normalized name: Teriparatide
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Teriparatide after prior treatment with alendronate
Trial: 15885613
Drug: Identification of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Identification of specific impairing drugs
Trial: 12817157
Drug: Risperidone (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risperidone (mean daily dose 2 mg, range 0.5-4 mg) added to mood stabilizers
Trial: 10440305
Drug: Live, attenuated
RxNorm normalized name: Ebola Zaire vaccine (live, attenuated)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live, attenuated human rotavirus vaccine 89-12 (1x10^5 plaque-forming units)
Trial: 12404166
Drug: Live, attenuated
RxNorm normalized name: Ebola Zaire vaccine (live, attenuated)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live, attenuated human rotavirus vaccine 89-12
Trial: 7825537
Drug: Soy formula
RxNorm normalized name: Nursoy Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy formula with added selenate (SF+Se, 0.17 mumol Se/L)
Trial: 7825537
Drug: Soy formula
RxNorm normalized name: Nursoy Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy formula (SF, 0.028 mumol Se/L)
Trial: 2141057
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ibuprofen and fenoterol (IBF)
Trial: 638411
Drug: Dietary restriction
RxNorm normalized name: sodium phosphate, monobasic
DrugBank: Sodium phosphate, monobasic (DB09449)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary restriction and laxatives
Trial: 7575762
Drug: Chondroitin sulfate
RxNorm normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulfate (0.8 g single daily dose)
Trial: 7575762
Drug: Chondroitin sulfate
RxNorm normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulfate (0.4 g two daily doses)
Trial: 2256719
Drug: Chemoresistance testing
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoresistance testing at initiation of therapy
Trial: 6989684
Drug: tolciclate 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tolciclate 1% cream
Trial: 6989684
Drug: miconazole 2%
RxNorm normalized name: MICONAZOLE 200MG SUPP/MICONAZOLE 2% CREAM PAK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: miconazole 2% cream
Trial: 26536843
Drug: Treatment-as-usual (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-as-usual (control group) for high-risk patients
Trial: 18271282
Drug: 400 mg/day
RxNorm normalized name: ribociclib succinate 400 mg/day (200 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg/day vitamin E (E400)
Trial: 18271282
Drug: 200 mg/day
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/day vitamin E (E200)
Trial: 18271282
Drug: 250 mg/day
RxNorm normalized name: alpelisib 250 mg/day (200 mg x 1 and 50 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg/day vitamin C (C250)
Trial: 15673408
Drug: Pexelizumab bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pexelizumab bolus (2.0 mg/kg) + placebo infusion